OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,272,650 | -99.7% | 186,060 | +84.0% | 0.00% | – |
| Q1 2022 | $500,560,000 | -9.2% | 101,123 | +27.9% | 0.00% | – |
| Q4 2021 | $551,035,000 | -19.7% | 79,058 | +15.2% | 0.00% | – |
| Q3 2021 | $686,210,000 | -35.7% | 68,621 | -8.8% | 0.00% | – |
| Q2 2021 | $1,066,620,000 | +4.1% | 75,220 | +20.5% | 0.00% | – |
| Q1 2021 | $1,024,772,000 | -1.3% | 62,448 | +24.6% | 0.00% | – |
| Q4 2020 | $1,037,836,000 | – | 50,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |